Skip to main content

Table 5 Correlations between IOCv2 dimensions and sociodemographic and treatment characteristics and mean scores of IOCv2 dimensions

From: Validation of the French translation-adaptation of the impact of cancer questionnaire version 2 (IOCv2) in a breast cancer survivor population

   

Chemotherapy

Radiotherapy

Surgery

Hormonotherapy

Partnered

 

Time since diagnosis

Age

No

Yes

No

Yes

No

Yes

No

Yes

No

Yes

N = 64

N = 142

N = 11

N = 218

N = 6

N = 219

N = 60

N = 146

N = 58

N = 183

Positive impact dimensions

SS

−0.05

−0.13*

3.28

3.43

3.65

3.37

3.42

3.39

3.40

3.42

3.37

3.47

AE

0.01

−0.08

3.56

3.73

3.68

3.68

3.63

3.70

3.72

3.71

3.71

3.68

HA

−0.08

−0.17*

3.75

3.86

4.00

3.80

4.00

3.81

3.80

3.88

3.87

3.80

MOC

0.01

−0.02

2.74

2.90

3.45*

2.83*

2.77

2.86

2.89

2.91

2.99

2.84

PSE

−0.08

−0.11

3.21

3.38

3.52

3.32

3.50

3.34

3.36

3.32

3.42

3.31

Negative impact dimensions

SS

−0.04

−0.04

2.70

2.92

2.66

2.85

3.12

2.85

2.77

2.91

2.85

2.91

AC

−0.03

−0.12

2.44*

2.85*

2.73

2.70

2.93

2.71

2.42*

2.82*

2.70

2.78

BCC

−0.05

−0.01

2.93

3.18

2.61

3.08

3.17

3.08

2.9

3.18

3.05

3.09

LI

−0.01

0.00

2.30

2.47

2.17

2.43

2.71

2.42

2.39

2.47

2.54

2.38

W

−0.04

−0.03

3.11

3.31

3.14

3.25

3.54

3.25

3.25

3.29

3.31

3.25

   

N = 28

N = 73

N = 5

N = 100

N = 3

N = 101

N = 27

N = 71

N = 79

N = 27

EC

−0.06

0.07

2.21

2.48

2.27

2.43

2.56

2.42

2.53

2.34

2.40

2.44

   

N = 11

N = 40

N = 2

N = 53

N = 1

N = 53

N = 10

N = 42

  

NP

−0.14

0.03

2.33

2.75

2.50

2.63

NA

NA

3.33*

2.42*

  
   

N = 51

N = 95

N = 9

N = 155

N = 4

N = 158

N = 45

N = 103

  

P

0.13

0.19*

1.77

1.78

1.33*

1.82*

2.38

1.77

1.63

1.85

  
  1. * p value of the t test < 0.05
  2. NA: not applicable